Keywords: Alexion Pharma, Enobia Pharma, M&A, Asfotase alfa, ENB-0040, Hypophosphatasia

Alexion to buy Enobia Pharma for potential $1 billion

Article | 30 December 2011

US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) has reached agreement to acquire privately held Canadian firm Enobia Pharma, which is focused ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alexion Pharmaceuticals

Enobia Pharma

Go to company listing

Related Drugs

asfotase alfa

Go to drug listing